Panagora Asset Management Inc Atossa Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.6 - $3.27 $42,760 - $87,390	-26,725 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$1.52 - $8.62 $40,622 - $230,369	26,725 New	26,725 $169,000
Q1 2019 May 15, 2019	SELL	$1.11 - $7.07 $12,493 - $79,572	-11,255 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$0.92 - $1.67 $2,172 - $3,942	-2,361 Reduced 17.34%	11,255 $11,000
Q3 2018 Nov 13, 2018	BUY	$1.47 - $2.78 $20,015 - $37,852	13,616 New	13,616 $24,000

29M

39.8K

90.9K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $105M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.